10-K Filing
Filing Information
| Form Type | 10-K |
| Accession Number | 0001437749-22-004317 |
| Period End Date | 20211231 |
| Filing Date | 20220224 |
| Fiscal Year | 2021 |
| Fiscal Period | FY |
| XBRL Instance | aqms20211231_10k_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
67 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$8.14M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$6.53M | USD | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Common stock, shares authorized (in shares) |
CommonStockSharesAuthorized
|
100.00M | shares | Point-in-time |
| Accounts receivable |
AccountsReceivableNetCurrent
|
$32.00K | USD | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
64.46M | shares | Point-in-time |
| Common stock, shares issued (in shares) |
CommonStockSharesIssued
|
70.42M | shares | Point-in-time |
| Accounts receivable |
AccountsReceivableNetCurrent
|
$269.00K | USD | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
70.42M | shares | Point-in-time |
| Common stock, shares outstanding (in shares) |
CommonStockSharesOutstanding
|
64.46M | shares | Point-in-time |
| Lease receivable, current portion |
SalesTypeLeaseNetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
|
$920.00K | USD | Point-in-time |
| Lease receivable, current portion |
SalesTypeLeaseNetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLossCurrent
|
- | USD | Point-in-time |
| Inventory |
InventoryNet
|
$123.00K | USD | Point-in-time |
| Inventory |
InventoryNet
|
$1.09M | USD | Point-in-time |
| Assets held for sale |
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
|
- | USD | Point-in-time |
| Assets held for sale |
AssetsHeldForSaleNotPartOfDisposalGroupCurrent
|
$2.63M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$702.00K | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$356.00K | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$12.44M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$8.36M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$24.88M | USD | Point-in-time |
| Property and equipment, net |
PropertyPlantAndEquipmentNet
|
$2.37M | USD | Point-in-time |
| Intellectual property, net |
FiniteLivedIntangibleAssetsNet
|
$640.00K | USD | Point-in-time |
| Intellectual property, net |
FiniteLivedIntangibleAssetsNet
|
$819.00K | USD | Point-in-time |
| Investment in LINICO |
LongTermInvestments
|
- | USD | Point-in-time |
| Investment in LINICO |
LongTermInvestments
|
$1.50M | USD | Point-in-time |
| Lease receivable, non-current portion |
SalesTypeLeaseNetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent
|
- | USD | Point-in-time |
| Lease receivable, non-current portion |
SalesTypeLeaseNetInvestmentInLeaseExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent
|
$15.53M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$796.00K | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$1.08M | USD | Point-in-time |
| Total non-current assets |
AssetsNoncurrent
|
$20.83M | USD | Point-in-time |
| Total non-current assets |
AssetsNoncurrent
|
$26.78M | USD | Point-in-time |
| Total assets |
Assets
|
$35.14M | USD | Point-in-time |
| Total assets |
Assets
|
$33.27M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$1.55M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$685.00K | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$3.00M | USD | Point-in-time |
| Accrued expenses |
AccruedLiabilitiesCurrent
|
$1.25M | USD | Point-in-time |
| Lease liability, current portion |
OperatingAndFinanceLeaseLiabilityCurrent
|
$388.00K | USD | Point-in-time |
| Lease liability, current portion |
OperatingAndFinanceLeaseLiabilityCurrent
|
$620.00K | USD | Point-in-time |
| Notes payable, current portion |
NotesPayableCurrent
|
- | USD | Point-in-time |
| Notes payable, current portion |
NotesPayableCurrent
|
$29.00K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$4.08M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$3.45M | USD | Point-in-time |
| Building purchase deposit |
BuildingPurchaseDepositNoncurrent
|
$1.33M | USD | Point-in-time |
| Building purchase deposit |
BuildingPurchaseDepositNoncurrent
|
- | USD | Point-in-time |
| Lease liability, non-current portion |
OperatingAndFinanceLeaseLiabilityNoncurrent
|
$242.00K | USD | Point-in-time |
| Lease liability, non-current portion |
OperatingAndFinanceLeaseLiabilityNoncurrent
|
$330.00K | USD | Point-in-time |
| Notes payable, non-current portion |
LongTermNotesPayable
|
- | USD | Point-in-time |
| Notes payable, non-current portion |
LongTermNotesPayable
|
$303.00K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$4.00M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$5.74M | USD | Point-in-time |
| Commitments and contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Common stock; $0.001 par value; 100,000,000 shares authorized; 70,416,552 and 64,461,065 shares issued and outstanding as of December 31, 2021 and December 31, 2020, respectively |
CommonStockValue
|
$70.00K | USD | Point-in-time |
| Common stock; $0.001 par value; 100,000,000 shares authorized; 70,416,552 and 64,461,065 shares issued and outstanding as of December 31, 2021 and December 31, 2020, respectively |
CommonStockValue
|
$64.00K | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$196.73M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$211.31M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-165.65M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-183.85M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquity
|
$49.59M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquity
|
$31.14M | USD | Point-in-time |
| Total stockholders equity |
StockholdersEquity
|
$27.53M | USD | Point-in-time |
| Total liabilities and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$33.27M | USD | Point-in-time |
| Total liabilities and stockholders equity |
LiabilitiesAndStockholdersEquity
|
$35.14M | USD | Point-in-time |
Income Statement
36 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Product sales |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$173.00K | USD | Annual |
| Product sales |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$108.00K | USD | Annual |
| Cost of product sales |
CostOfGoodsAndServicesSold
|
$7.02M | USD | Annual |
| Cost of product sales |
CostOfGoodsAndServicesSold
|
$5.48M | USD | Annual |
| Research and development cost |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$933.00K | USD | Annual |
| Research and development cost |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$1.03M | USD | Annual |
| General and administrative expense |
GeneralAndAdministrativeExpense
|
$9.00M | USD | Annual |
| General and administrative expense |
GeneralAndAdministrativeExpense
|
$9.69M | USD | Annual |
| Total operating expense |
CostsAndExpenses
|
$15.50M | USD | Annual |
| Total operating expense |
CostsAndExpenses
|
$17.64M | USD | Annual |
| Loss from operations |
OperatingIncomeLoss
|
$-17.46M | USD | Annual |
| Loss from operations |
OperatingIncomeLoss
|
$-15.39M | USD | Annual |
| Insurance proceeds net of related expenses |
InsuranceRecoveriesNetOfRelatedExpenses
|
$4.79M | USD | Annual |
| Insurance proceeds net of related expenses |
InsuranceRecoveriesNetOfRelatedExpenses
|
$2.95M | USD | Annual |
| Impairment expense |
ImpairmentOfLongLivedAssetsHeldForUse
|
$545.00K | USD | Annual |
| Impairment expense |
ImpairmentOfLongLivedAssetsHeldForUse
|
$11.74M | USD | Annual |
| PPP loan forgiveness |
GainsLossesOnExtinguishmentOfDebt
|
- | USD | Annual |
| PPP loan forgiveness |
GainsLossesOnExtinguishmentOfDebt
|
$332.00K | USD | Annual |
| Loss on disposal of property and equipment |
GainLossOnSaleOfPropertyPlantAndEquipmentExcludingAmountInCostOfGoodSold
|
$-5.67M | USD | Annual |
| Loss on disposal of property and equipment |
GainLossOnSaleOfPropertyPlantAndEquipmentExcludingAmountInCostOfGoodSold
|
- | USD | Annual |
| Interest expense |
InterestExpense
|
$21.00K | USD | Annual |
| Interest expense |
InterestExpense
|
$1.62M | USD | Annual |
| Interest and other income |
InterestAndOtherIncome
|
$48.00K | USD | Annual |
| Interest and other income |
InterestAndOtherIncome
|
$379.00K | USD | Annual |
| Total other expense, net |
NonoperatingIncomeExpense
|
$-726.00K | USD | Annual |
| Total other expense, net |
NonoperatingIncomeExpense
|
$-10.37M | USD | Annual |
| Loss before income tax expense |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$-18.19M | USD | Annual |
| Loss before income tax expense |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$-25.76M | USD | Annual |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$2.00K | USD | Annual |
| Income tax expense |
IncomeTaxExpenseBenefit
|
$2.00K | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-25.76M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-18.19M | USD | Annual |
| Weighted average shares outstanding, basic and diluted (in shares) |
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
70.00M | shares | Annual |
| Weighted average shares outstanding, basic and diluted (in shares) |
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
60.86M | shares | Annual |
| Basic and diluted net loss per share (in dollars per share) |
EarningsPerShareBasicAndDiluted
|
$-0.26 | USD | Annual |
| Basic and diluted net loss per share (in dollars per share) |
EarningsPerShareBasicAndDiluted
|
$-0.42 | USD | Annual |
Cash Flow Statement
88 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
NetIncomeLoss
|
$-25.76M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-18.19M | USD | Annual |
| Depreciation |
DepreciationAndRightOfUseAssetAmortization
|
$2.23M | USD | Annual |
| Depreciation |
DepreciationAndRightOfUseAssetAmortization
|
$1.14M | USD | Annual |
| Amortization of intellectual property |
AmortizationOfIntangibleAssets
|
$180.00K | USD | Annual |
| Amortization of intellectual property |
AmortizationOfIntangibleAssets
|
$180.00K | USD | Annual |
| Accretion of asset retirement obligation |
AssetRetirementObligationAccretionExpense
|
- | USD | Annual |
| Accretion of asset retirement obligation |
AssetRetirementObligationAccretionExpense
|
$45.00K | USD | Annual |
| Fair value of common stock issued for consulting services |
FairValueOfCommonStockIssuedForConsultingServices
|
$64.00K | USD | Annual |
| Fair value of common stock issued for consulting services |
FairValueOfCommonStockIssuedForConsultingServices
|
$225.00K | USD | Annual |
| Stock-based compensation |
ShareBasedCompensation
|
$3.57M | USD | Annual |
| Stock-based compensation |
ShareBasedCompensation
|
$2.20M | USD | Annual |
| Amortization of deferred financing costs |
AmortizationOfFinancingCosts
|
$607.00K | USD | Annual |
| Amortization of deferred financing costs |
AmortizationOfFinancingCosts
|
- | USD | Annual |
| Inventory NRV adjustment |
InventoryWriteDown
|
$146.00K | USD | Annual |
| Inventory NRV adjustment |
InventoryWriteDown
|
- | USD | Annual |
| Loss on disposal of property and equipment |
GainLossOnSaleOfPropertyPlantEquipment
|
$-5.67M | USD | Annual |
| Loss on disposal of property and equipment |
GainLossOnSaleOfPropertyPlantEquipment
|
$-90.00K | USD | Annual |
| Forgiveness of PPP loan |
GainsLossesOnExtinguishmentOfDebt
|
- | USD | Annual |
| Forgiveness of PPP loan |
GainsLossesOnExtinguishmentOfDebt
|
$332.00K | USD | Annual |
| Impairment of equipment |
ImpairmentOfLongLivedAssetsHeldForUse
|
$545.00K | USD | Annual |
| Impairment of equipment |
ImpairmentOfLongLivedAssetsHeldForUse
|
$11.74M | USD | Annual |
| Retirement of asset retirement obligation |
AssetRetirementObligationLiabilitiesSettled
|
- | USD | Annual |
| Retirement of asset retirement obligation |
AssetRetirementObligationLiabilitiesSettled
|
$521.00K | USD | Annual |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$-212.00K | USD | Annual |
| Accounts receivable |
IncreaseDecreaseInAccountsReceivable
|
$237.00K | USD | Annual |
| Inventory |
IncreaseDecreaseInInventories
|
$-166.00K | USD | Annual |
| Inventory |
IncreaseDecreaseInInventories
|
$-822.00K | USD | Annual |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-345.00K | USD | Annual |
| Prepaid expenses and other current assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-280.00K | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$-2.00M | USD | Annual |
| Accounts payable |
IncreaseDecreaseInAccountsPayable
|
$8.00K | USD | Annual |
| Accrued expenses |
IncreaseDecreaseInAccruedLiabilities
|
$-2.45M | USD | Annual |
| Accrued expenses |
IncreaseDecreaseInAccruedLiabilities
|
$378.00K | USD | Annual |
| Other assets and liabilities |
IncreaseDecreaseInOtherOperatingCapitalNet
|
$528.00K | USD | Annual |
| Other assets and liabilities |
IncreaseDecreaseInOtherOperatingCapitalNet
|
$508.00K | USD | Annual |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-7.62M | USD | Annual |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-11.03M | USD | Annual |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$2.35M | USD | Annual |
| Purchases of property and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$3.36M | USD | Annual |
| Proceeds from sale of equipment |
ProceedsFromSaleOfPropertyPlantAndEquipment
|
$162.00K | USD | Annual |
| Proceeds from sale of equipment |
ProceedsFromSaleOfPropertyPlantAndEquipment
|
$275.00K | USD | Annual |
| Equipment deposits and other assets |
PaymentsToAcquireEquipmentDepositsAndOtherAssets
|
$-79.00K | USD | Annual |
| Equipment deposits and other assets |
PaymentsToAcquireEquipmentDepositsAndOtherAssets
|
$4.00K | USD | Annual |
| Insurance proceeds |
ProceedsFromInsuranceSettlementInvestingActivities
|
- | USD | Annual |
| Insurance proceeds |
ProceedsFromInsuranceSettlementInvestingActivities
|
$9.84M | USD | Annual |
| Investment in LINICO |
PaymentsToAcquireInvestments
|
$232.00K | USD | Annual |
| Investment in LINICO |
PaymentsToAcquireInvestments
|
- | USD | Annual |
| Net cash provided by (used in) investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-2.23M | USD | Annual |
| Net cash provided by (used in) investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$6.63M | USD | Annual |
| Proceeds from PPP loan |
ProceedsFromLinesOfCredit
|
$332.00K | USD | Annual |
| Proceeds from PPP loan |
ProceedsFromLinesOfCredit
|
- | USD | Annual |
| Payments on notes payable |
RepaymentsOfNotesPayable
|
$654.00K | USD | Annual |
| Payments on notes payable |
RepaymentsOfNotesPayable
|
- | USD | Annual |
| Lease of building |
ProceedsFromSalesTypeLeasePaymentsFinancingActivities
|
- | USD | Annual |
| Lease of building |
ProceedsFromSalesTypeLeasePaymentsFinancingActivities
|
$553.00K | USD | Annual |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$728.00K | USD | Annual |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
- | USD | Annual |
| Proceeds from ATM, net |
ProceedsFromIssuanceOfCommonStock
|
$3.68M | USD | Annual |
| Proceeds from ATM, net |
ProceedsFromIssuanceOfCommonStock
|
$10.17M | USD | Annual |
| Net cash provided by (used in) financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$3.35M | USD | Annual |
| Net cash provided by (used in) financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$11.45M | USD | Annual |
| Net increase (decrease) in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$1.60M | USD | Annual |
| Net increase (decrease) in cash, cash equivalents and restricted cash |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-1.04M | USD | Annual |
| Cash, cash equivalents and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$6.53M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$7.58M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$8.14M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$6.53M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$7.58M | USD | Point-in-time |
| Cash, cash equivalents and restricted cash at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$8.14M | USD | Point-in-time |
| Cash paid for interest, net of amounts capitalized |
InterestPaidNet
|
$1.04M | USD | Annual |
| Cash paid for interest, net of amounts capitalized |
InterestPaidNet
|
$21.00K | USD | Annual |
| Cash paid for income taxes |
IncomeTaxesPaid
|
$2.00K | USD | Annual |
| Cash paid for income taxes |
IncomeTaxesPaid
|
$2.00K | USD | Annual |
| Fair value of common stock issued to consultants |
StockIssued1
|
$91.00K | USD | Annual |
| Fair value of common stock issued to consultants |
StockIssued1
|
$64.00K | USD | Annual |
| Change in property and equipment resulting from change in accounts payable |
ChangeInPropertyAndEquipmentResultingFromChangeInAccountsPayable
|
$1.28M | USD | Annual |
| Change in property and equipment resulting from change in accounts payable |
ChangeInPropertyAndEquipmentResultingFromChangeInAccountsPayable
|
$875.00K | USD | Annual |
| Change in property and equipment resulting from change in accrued expenses |
ChangeInPropertyAndEquipmentResultingFromChangeInAccruedExpenses
|
- | USD | Annual |
| Change in property and equipment resulting from change in accrued expenses |
ChangeInPropertyAndEquipmentResultingFromChangeInAccruedExpenses
|
$431.00K | USD | Annual |
| Change in equity resulting from change in accrued expenses |
ChangeInEquityResultingFromChangeInAccruedExpenses
|
$24.00K | USD | Annual |
| Change in equity resulting from change in accrued expenses |
ChangeInEquityResultingFromChangeInAccruedExpenses
|
- | USD | Annual |
| Change in investing activity resulting from issuance of equity |
ChangeInInvestingActivityResultingFromIssuanceOfEquity
|
- | USD | Annual |
| Change in investing activity resulting from issuance of equity |
ChangeInInvestingActivityResultingFromIssuanceOfEquity
|
$-1.27M | USD | Annual |
| Change in other assets to extinguish notes payable |
ChangeInOtherAssetsToExtinguishNotesPayable
|
$8.65M | USD | Annual |
| Change in other assets to extinguish notes payable |
ChangeInOtherAssetsToExtinguishNotesPayable
|
- | USD | Annual |
| Change in insurance proceeds receivable resulting from insurance funds held in escrow |
ChangeInAccountsReceivableResultingFromInsuranceFundsHeldInEscrow
|
- | USD | Annual |
| Change in insurance proceeds receivable resulting from insurance funds held in escrow |
ChangeInAccountsReceivableResultingFromInsuranceFundsHeldInEscrow
|
$7.94M | USD | Annual |
Stockholders Equity
24 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Common stock issued, transaction costs |
PaymentsOfStockIssuanceCosts
|
$339.00K | USD | Annual |
| Common stock issued, transaction costs |
PaymentsOfStockIssuanceCosts
|
$216.00K | USD | Annual |
| Balance |
StockholdersEquity
|
$49.59M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$31.14M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$27.53M | USD | Point-in-time |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$3.57M | USD | Annual |
| Stock-based compensation |
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
$2.20M | USD | Annual |
| Common stock issued upon RSU vesting (in shares) |
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
|
691,820.00 | shares | Annual |
| Common stock issued upon RSU vesting |
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
$2.00K | USD | Annual |
| Common stock issued upon RSU vesting |
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
|
$3.00K | USD | Annual |
| Common stock issued for consulting services |
StockIssuedDuringPeriodValueIssuedForServices
|
$225.00K | USD | Annual |
| Common stock issued for consulting services |
StockIssuedDuringPeriodValueIssuedForServices
|
$64.00K | USD | Annual |
| Common stock issued for ATM share sales, net |
StockIssuedDuringPeriodValueNewIssues
|
$10.17M | USD | Annual |
| Common stock issued for ATM share sales, net |
StockIssuedDuringPeriodValueNewIssues
|
$3.68M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-25.76M | USD | Annual |
| Net loss |
NetIncomeLoss
|
$-18.19M | USD | Annual |
| Common stock issued upon exercise of employee stock options (in shares) |
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0.00 | shares | Annual |
| Common stock issued upon exercise of employee stock options (in shares) |
StockIssuedDuringPeriodSharesStockOptionsExercised
|
347,901.00 | shares | Annual |
| Common stock issued upon exercise of employee stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$727.00K | USD | Annual |
| Common stock issued upon warrant exercise |
StockIssuedDuringPeriodValueWarrantExercised
|
- | USD | Annual |
| Common stock issued related to LINICO investment |
StockIssuedDuringPeriodValueInvestment
|
$1.27M | USD | Annual |
| Balance |
StockholdersEquity
|
$49.59M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$31.14M | USD | Point-in-time |
| Balance |
StockholdersEquity
|
$27.53M | USD | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.